SK16798A3 - 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen- -1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof - Google Patents
1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen- -1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof Download PDFInfo
- Publication number
- SK16798A3 SK16798A3 SK167-98A SK16798A SK16798A3 SK 16798 A3 SK16798 A3 SK 16798A3 SK 16798 A SK16798 A SK 16798A SK 16798 A3 SK16798 A3 SK 16798A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- derivative
- dihydro
- compound
- methoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9509684A FR2737724B1 (fr) | 1995-08-09 | 1995-08-09 | Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4- (naphtalen-1-yl) piperazine, leur preparation et leur application en therapeutique |
PCT/FR1996/001216 WO1997006155A1 (fr) | 1995-08-09 | 1996-08-01 | Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
SK16798A3 true SK16798A3 (en) | 1998-08-05 |
Family
ID=9481836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK167-98A SK16798A3 (en) | 1995-08-09 | 1996-08-01 | 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen- -1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof |
Country Status (20)
Country | Link |
---|---|
US (1) | US5929078A (pt) |
EP (1) | EP0843670A1 (pt) |
JP (1) | JP2000501699A (pt) |
KR (1) | KR19990035954A (pt) |
CN (1) | CN1199398A (pt) |
AR (1) | AR003222A1 (pt) |
AU (1) | AU707372B2 (pt) |
BR (1) | BR9609977A (pt) |
CA (1) | CA2228843A1 (pt) |
CO (1) | CO4750833A1 (pt) |
CZ (1) | CZ36898A3 (pt) |
FR (1) | FR2737724B1 (pt) |
HU (1) | HUP9802546A3 (pt) |
IL (1) | IL123187A0 (pt) |
NO (1) | NO980529L (pt) |
NZ (1) | NZ315363A (pt) |
PL (1) | PL324966A1 (pt) |
SK (1) | SK16798A3 (pt) |
WO (1) | WO1997006155A1 (pt) |
ZA (1) | ZA966772B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI242011B (en) | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
US8106074B2 (en) * | 2001-07-13 | 2012-01-31 | Pierre Fabre Medicament | Pyridin-2-yl-methylamine derivatives for treating opiate dependence |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE358300A (pt) * | 1928-04-28 | |||
US2927924A (en) * | 1958-04-03 | 1960-03-08 | Lilly Co Eli | Novel phenethyl-substituted piperazines |
NL132357C (pt) * | 1966-09-03 | |||
DE2037852C3 (de) * | 1970-07-30 | 1980-06-26 | Boehringer Sohn Ingelheim | Neue Piperazinderivate und Verfahren zu ihrer Herstellung |
WO1995018118A1 (en) * | 1993-12-28 | 1995-07-06 | The Upjohn Company | Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
FR2716193B1 (fr) * | 1994-02-16 | 1996-04-05 | Synthelabo | Dérivés de 1[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur préparation et leur application en thérapeutique. |
-
1995
- 1995-08-09 FR FR9509684A patent/FR2737724B1/fr not_active Expired - Fee Related
-
1996
- 1996-08-01 IL IL12318796A patent/IL123187A0/xx unknown
- 1996-08-01 EP EP96927120A patent/EP0843670A1/fr not_active Withdrawn
- 1996-08-01 JP JP9508161A patent/JP2000501699A/ja active Pending
- 1996-08-01 US US09/011,807 patent/US5929078A/en not_active Expired - Fee Related
- 1996-08-01 WO PCT/FR1996/001216 patent/WO1997006155A1/fr not_active Application Discontinuation
- 1996-08-01 KR KR1019980700615A patent/KR19990035954A/ko not_active Application Discontinuation
- 1996-08-01 PL PL96324966A patent/PL324966A1/xx unknown
- 1996-08-01 BR BR9609977A patent/BR9609977A/pt not_active Application Discontinuation
- 1996-08-01 CA CA002228843A patent/CA2228843A1/en not_active Abandoned
- 1996-08-01 AU AU67053/96A patent/AU707372B2/en not_active Ceased
- 1996-08-01 CN CN96197512A patent/CN1199398A/zh active Pending
- 1996-08-01 SK SK167-98A patent/SK16798A3/sk unknown
- 1996-08-01 NZ NZ315363A patent/NZ315363A/xx unknown
- 1996-08-01 CZ CZ98368A patent/CZ36898A3/cs unknown
- 1996-08-01 HU HU9802546A patent/HUP9802546A3/hu unknown
- 1996-08-06 CO CO96041580A patent/CO4750833A1/es unknown
- 1996-08-08 AR ARP960103928A patent/AR003222A1/es unknown
- 1996-08-08 ZA ZA9606772A patent/ZA966772B/xx unknown
-
1998
- 1998-02-06 NO NO980529A patent/NO980529L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO980529D0 (no) | 1998-02-06 |
US5929078A (en) | 1999-07-27 |
WO1997006155A1 (fr) | 1997-02-20 |
AU707372B2 (en) | 1999-07-08 |
BR9609977A (pt) | 1999-01-12 |
HUP9802546A3 (en) | 1999-10-28 |
JP2000501699A (ja) | 2000-02-15 |
CZ36898A3 (cs) | 1998-05-13 |
NO980529L (no) | 1998-04-14 |
PL324966A1 (en) | 1998-06-22 |
MX9801057A (es) | 1998-05-31 |
ZA966772B (en) | 1997-02-19 |
IL123187A0 (en) | 1998-09-24 |
AU6705396A (en) | 1997-03-05 |
AR003222A1 (es) | 1998-07-08 |
FR2737724A1 (fr) | 1997-02-14 |
HUP9802546A2 (hu) | 1999-02-01 |
NZ315363A (en) | 1998-10-28 |
EP0843670A1 (fr) | 1998-05-27 |
CO4750833A1 (es) | 1999-03-31 |
FR2737724B1 (fr) | 1997-09-05 |
CA2228843A1 (en) | 1997-02-20 |
CN1199398A (zh) | 1998-11-18 |
KR19990035954A (ko) | 1999-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5935958A (en) | Muscarinic antagonists | |
US8278338B2 (en) | Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety | |
US5932734A (en) | N-aminoalkylfluorenecarboxamides | |
US5010079A (en) | Indolone derivatives, their preparation and their application in therapy | |
US5143916A (en) | Naphthylpiperazines useful as 5-ht1a receptor ligands | |
US5286735A (en) | Derivatives of 4-aminomethylpiperidine, their preparation and their use as therapeutics | |
US5179108A (en) | Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application | |
JP2000086603A (ja) | 桂皮酸アミド誘導体および3―フェニルプロピオン酸アミド誘導体 | |
CZ210694A3 (en) | Derivatives of piperidine, their use for preparing pharmaceutical preparations, process of their preparation, intermediates for preparing thereof and pharmaceutical compositions based thereon | |
AU644296B2 (en) | 2-(1-piperidyl)ethanol derivatives, their preparation and their therapeutic application | |
EP1978959B1 (en) | Piperidine and piperazine derivatives | |
JPH0225481A (ja) | 2―[(4―ピペリジニル)メチル]―1,2,3,4―テトラヒドロイソキノリン誘導体、その製造方法およびその治療への適用 | |
US5166156A (en) | Naphthyl piperazines useful as 5-HT1A receptor ligands | |
SK16798A3 (en) | 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen- -1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof | |
US5486527A (en) | Anticholinergic agents | |
US4826975A (en) | Fused cycloaliphatic aminoalcohols | |
US4902799A (en) | Bicyclic alkoxy- and alkylthio-substituted aminoalcohols | |
US5703237A (en) | N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands | |
AU680327B2 (en) | 1-(2-(1H-inden-3-yl)ethyl)-4-(naphth-1-yl)piperazine derivatives, their preparation and their application in therapeutics | |
US5166157A (en) | Naphthyl piperazines useful as 5-HT1A receptor ligands | |
JPH0725851A (ja) | ピペリジン類およびピペラジン類 | |
PL143992B1 (en) | Process for preparing novel derivatives of phenylacetic acid | |
PL184412B1 (pl) | Nowe pochodne 3,3a,4,5-tetrahydro-1H-oksazolo [3,4-a] chinolin-1-onu, sposób ich wytwarzania i preparat farmaceutyczny | |
WO1987002035A1 (en) | Fused cycloaliphatic aminoalcohols | |
AU1487299A (en) | Biphenyl derivatives as pharmaceuticals |